Croda International Plc (LON:CRDA) Insider Buys £100,483.02 in Stock

Key Points

• Insider Stephen Oxley purchased 3,762 shares of Croda International Plc at an average cost of GBX 2,671 ($35.67), totaling £100,483.02 ($134,192.07) on July 29th.
• The company reported an EPS of GBX 72.20 ($0.96) for the quarter and is projected to reach 181.83 EPS for the current fiscal year.
• Analysts have mixed views, with Citigroup lowering their target price to GBX 3,300 ($44.07) while Berenberg Bank maintains a "buy" rating with a target of GBX 3,800 ($50.75).

Croda International Plc (LON:CRDA - Get Free Report) insider Stephen Oxley purchased 3,762 shares of the stock in a transaction dated Tuesday, July 29th. The shares were acquired at an average cost of GBX 2,671 ($35.45) per share, for a total transaction of £100,483.02 ($133,372.74).

Croda International Trading Up 0.6%

LON CRDA traded up GBX 15 ($0.20) on Friday, hitting GBX 2,627 ($34.87). 536,042 shares of the company were exchanged, compared to its average volume of 1,088,552. Croda International Plc has a twelve month low of GBX 2,527 ($33.54) and a twelve month high of GBX 4,335 ($57.54). The company's 50 day moving average price is GBX 2,967.84 and its 200-day moving average price is GBX 3,025.97. The firm has a market capitalization of £3.67 billion, a P/E ratio of 22.57, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74. The company has a debt-to-equity ratio of 30.90, a current ratio of 2.72 and a quick ratio of 2.25.

Croda International (LON:CRDA - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The company reported GBX 72.20 ($0.96) EPS for the quarter. Croda International had a net margin of 9.98% and a return on equity of 6.96%. Analysts predict that Croda International Plc will post 181.8307268 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on CRDA shares. JPMorgan Chase & Co. raised Croda International to an "overweight" rating in a report on Wednesday. Citigroup dropped their price target on shares of Croda International from GBX 3,550 ($47.12) to GBX 3,300 ($43.80) and set a "neutral" rating on the stock in a research report on Tuesday, April 29th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Croda International from GBX 3,400 ($45.13) to GBX 3,000 ($39.82) and set a "hold" rating on the stock in a research note on Tuesday. Finally, Berenberg Bank cut their target price on shares of Croda International from GBX 3,800 ($50.44) to GBX 3,100 ($41.15) and set a "buy" rating for the company in a research note on Tuesday.

About Croda International

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.